Categories: NewsPharmaceutical

Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution

OREM, Utah, May 07, 2024 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading provider of innovative cooling solutions, today announced sales of $105,000 attributable to the successful launch of the company’s state-of-the-art L-80 MAX and L-80 Lite chillers, which have revolutionized the aluminum heat treatment process in aerospace manufacturing.

The L-80 series chillers have been specially adapted for cooling isopropyl alcohol used in the quenching process of aluminum heat treatment. After extensive research and testing of various technologies, a leading aerospace manufacturer has chosen Reflect Scientific’s cutting-edge solution to enhance their operations. The L-80 MAX and L-80 Lite chillers offer unparalleled efficiency, precision, and safety, enabling manufacturers to increase production capacity while maintaining the highest quality standards.

“We are very pleased to witness the positive impact our L-80 series chillers are having on the aerospace manufacturing industry,” said Kim Boyce, CEO of Reflect Scientific Inc. “Our team has worked tirelessly to develop a solution that not only meets but exceeds the rigorous demands of this sector. The sales in the second quarter are a testament to the value our technology brings to our customers.”

The L-80 MAX and L-80 Lite chillers utilize patented liquid nitrogen cooling technology to rapidly reduce the temperature of isopropyl alcohol to -80°C with a precision of ±5°C in less than an hour. This capability accelerates the quenching process and allows for consistent and monitored bath temperatures, enhancing aerospace components’ strength and durability.

The success of the L-80 series chillers in the aerospace industry has opened doors for potential adoption in other sectors. Reflect Scientific Inc. is actively exploring opportunities to adapt its innovative cooling technology to meet the unique needs of various industries, including automotive, medical, and beyond.

For more information about Cryometrix chillers for cryo treatment and the groundbreaking L-80 series chillers, please visit https://tinyurl.com/2s43vnsf.

About Reflect Scientific, Inc.

Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”

CONTACT: Contact
Investor Relations
801-607-1039
investor_relations@reflectscientific.com

Staff

Recent Posts

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)…

2 hours ago

Neural Therapeutics Announces Changes to Board of Directors and Advisors

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"),…

3 hours ago

cbdMD Announces Publication of Human Clinical Trial Data

Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Newsweek Names Help at Home as One of America’s Greatest Workplaces 2024

Ranking includes factors such as diversity, culture, work-life balance, career opportunities CHICAGO, June 27, 2024…

3 hours ago

South Dakota Partners with Trualta to Support Family Caregivers

All caregivers in the state can access free resources at home PIERRE, S.D., June 27,…

3 hours ago

Lucius Partners Portfolio Company Algorithm Sciences, Inc. Closes on the Creation of a Majority Owned Subsidiary – Infusyn Therapeutics

Infusyn Therapeutics will manufacture and supply the Prometra II pump currently serving the Pain and…

3 hours ago